Ameriprise’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Buy |
750,161
+283,500
| +61% | +$4.91M | ﹤0.01% | 1624 |
|
|
2025
Q1 | $10.2M | Sell |
466,661
-416,140
| -47% | -$9.1M | ﹤0.01% | 1754 |
|
|
2024
Q4 | $28.2M | Buy |
882,801
+22,507
| +3% | +$718K | 0.01% | 1140 |
|
|
2024
Q3 | $24.8M | Buy |
860,294
+76,380
| +10% | +$2.2M | 0.01% | 1210 |
|
|
2024
Q2 | $30.1M | Buy |
783,914
+252,552
| +48% | +$9.69M | 0.01% | 1039 |
|
|
2024
Q1 | $31.2M | Sell |
531,362
-34,218
| -6% | -$2.01M | 0.01% | 1035 |
|
|
2023
Q4 | $33.9M | Buy |
565,580
+213,188
| +60% | +$12.8M | 0.01% | 959 |
|
|
2023
Q3 | $13.4M | Buy |
352,392
+211,314
| +150% | +$8.04M | ﹤0.01% | 1485 |
|
|
2023
Q2 | $12.9M | Buy |
141,078
+61,405
| +77% | +$5.59M | ﹤0.01% | 1581 |
|
|
2023
Q1 | $5.26M | Buy |
79,673
+22,033
| +38% | +$1.45M | ﹤0.01% | 2290 |
|
|
2022
Q4 | $2.98M | Buy |
57,640
+1,099
| +2% | +$56.8K | ﹤0.01% | 2612 |
|
|
2022
Q3 | $3.86M | Sell |
56,541
-122,163
| -68% | -$8.34M | ﹤0.01% | 2404 |
|
|
2022
Q2 | $8.08M | Buy |
178,704
+9,083
| +5% | +$411K | ﹤0.01% | 1908 |
|
|
2022
Q1 | $8.62M | Buy |
169,621
+2,933
| +2% | +$149K | ﹤0.01% | 2038 |
|
|
2021
Q4 | $7.88M | Sell |
166,688
-36,024
| -18% | -$1.7M | ﹤0.01% | 2158 |
|
|
2021
Q3 | $6.68M | Buy |
202,712
+68,555
| +51% | +$2.26M | ﹤0.01% | 2180 |
|
|
2021
Q2 | $8.48M | Buy |
+134,157
| New | +$8.48M | ﹤0.01% | 2062 |
|
|
2020
Q1 | – | Sell |
-19,200
| Closed | -$589K | – | 3635 |
|
|
2019
Q4 | $589K | Sell |
19,200
-1,300
| -6% | -$39.9K | ﹤0.01% | 3276 |
|
|
2019
Q3 | $494K | Sell |
20,500
-67,670
| -77% | -$1.63M | ﹤0.01% | 3302 |
|
|
2019
Q2 | $2.23M | Buy |
88,170
+40,112
| +83% | +$1.02M | ﹤0.01% | 2679 |
|
|
2019
Q1 | $937K | Buy |
+48,058
| New | +$937K | ﹤0.01% | 3060 |
|